Lead Product(s): Triethanolamine Salicylate
Therapeutic Area: Gastroenterology Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Tetra BioPharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership January 20, 2020
Tetra is finalizing a commercial supply agreement and initiating activities to secure private reimbursement for the two TERPACAN™ products.